Risk assessment and auditing of Quality Management systems, including QC/QA.

Griffin-Gamma LLC., consults in areas of Quality Systems Recovery/Development, Drug Design, Product Quality Assurance/Control, and Safety (FDA Drug Regulations 21 CFR 210, 211 and Device Regulation 820, and ISO Medical Device Standards 13485:2016, EU Regulations, TGA, Health Canada, Japan’s PMDA).
 
Griffin-Gamma LLC., assists companies with failed quality, regulatory, and operational/processing systems to become compliant under FDA 21CFR Parts 210, 211, 820 and also assists these companies to maintain clean records without damaging observations or 483s  during follow-up FDA Audits.

Authoring of global/corporate standard operating procedure (SOPs) for the pharmaceutical, cosmetic, and device plants.


Establishing preparatory programs for client quality and regulatory audits. Griffin-Gamma LLC., assists companies in developing of Standard Operating Procedures, Training and Compliance, Quality Audits and Inspections of pharmaceutical, cosmetic and medical device facilities.

This block contains code to allow dead links in the navigation to function properly. This block will not be visible on the live site.

DO NOT DELETE


Quality Systems / QA/QC / Validations

Pharmaceutical / Medical Device / Skincare / Cosmetic


Product and Process development and scale-up of pharmaceutical/medical products; Validation of manufacturing and production processes; Acquisition of pharmaceutical, cosmetic, and medical equipment.

Griffin-Gamma LLC., also assists companies to gain ISO 13485, ISO 22716, Health Canada, Australia's TGA certifications, and many other regulatory and international registrations.
 
Griffin-Gamma LLC., assists companies in developing of Standard Operating Procedures, Training and Compliance, Quality Audits and Inspections of pharmaceutical, cosmetic and medical device facilities.